What is the real importance of evaluating the expression of c-erbB-2 (HER-2/neu) in carcinoma of the breast and prostate? (A short review);Jaký je reálný význam hodnocení exprese c-erbB-2 (HER-2/neu) v karcinomech mlécné zlázy a prostaty? (Krátký prehledový clánek).

Ceskoslovenská patologie

Volumn 38 Suppl 1, Issue , 2002, Pages 15-19

  Kolar Z ^a   Dvorackova J ^a   Plevova P ^a   Student, V ^a   Hajduch M ^a   Trojanec, R ^a   Spackova K ^a  

^a PALACKÝ UNIVERSITY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; MONOCLONAL ANTIBODY; TRASTUZUMAB;

BREAST TUMOR; CARCINOMA; FEMALE; GENE AMPLIFICATION; GENETICS; HUMAN; MALE; PROGNOSIS; PROSTATE TUMOR; PROTO ONCOGENE; REVIEW;

ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CARCINOMA; FEMALE; GENE AMPLIFICATION; GENES, ERBB-2; HUMANS; MALE; PROGNOSIS; PROSTATIC NEOPLASMS;

EID: 0036984427     PISSN: 12107875     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (50)